Shanxi Zhendong Pharmaceutical Co.,Ltd

SZSE:300158 Stock Report

Market Cap: CN¥4.5b

Shanxi Zhendong PharmaceuticalLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Lianmin Yang

Chief executive officer

CN¥678.5k

Total compensation

CEO salary percentagen/a
CEO tenure3yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

Improved Revenues Required Before Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Stock's 39% Jump Looks Justified

Oct 22
Improved Revenues Required Before Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Stock's 39% Jump Looks Justified

We Think Shanxi Zhendong PharmaceuticalLtd (SZSE:300158) Can Afford To Drive Business Growth

Sep 30
We Think Shanxi Zhendong PharmaceuticalLtd (SZSE:300158) Can Afford To Drive Business Growth

Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Low P/S No Reason For Excitement

Aug 08
Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Low P/S No Reason For Excitement

Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Surges 31% Yet Its Low P/S Is No Reason For Excitement

Mar 07
Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Surges 31% Yet Its Low P/S Is No Reason For Excitement

CEO

Lianmin Yang (61 yo)

3yrs

Tenure

CN¥678,500

Compensation

Mr. Lianmin Yang is President of Shanxi Zhendong Pharmaceutical Co.,Ltd from December 02, 2021 and had been its Deputy General Manager since April 24, 2021 and serves as its Director. He has M.B.A. from Ch...

Leadership Team

NamePositionTenureCompensationOwnership
Lianmin Yang
President & Director3yrsCN¥678.50kno data
Changlu Liu
Head of Accounting & CFO6.2yrsCN¥375.40kno data
Zheyu Wang
VP & Secretary of the Board of Director1.6yrsCN¥521.50kno data
Xufeng Wang
Executive GM & Directorno datano datano data

3.0yrs

Average Tenure

40yo

Average Age

Experienced Management: 300158's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lianmin Yang
President & Directorno dataCN¥678.50kno data
Xufeng Wang
Executive GM & Director1.7yrsno datano data
Zhixiang Jin
Supervisor13yrsno data0.077%
CN¥ 3.4m
Ren Hu Li
Chairman of the Supervisory Board16yrsno data0.084%
CN¥ 3.7m
Zhimin Wang
Director16yrsCN¥83.30kno data
Jing Li
Director6.4yrsCN¥694.70kno data
Kun Li
Director2.7yrsCN¥688.30kno data
Lina Jin
Independent Directorless than a yearno datano data
Wanliang Lv
Independent Directorless than a yearno datano data
Xuemei Qin
Independent Director9.5yrsno datano data
Jiawen Ai
Non-Independent Directorless than a yearno datano data
Zhenhong Lei
Supervisorless than a yearno datano data

2.7yrs

Average Tenure

60yo

Average Age

Experienced Board: 300158's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:33
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanxi Zhendong Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wenchao JiaoPing An Securities Co. Ltd.
Yin YePing An Securities Co. Ltd.
Wen Qing WeiShenwan Hongyuan Securities